June June 29 : Capping a busy week, the FDA approved BioMarins Roctavian (valoctocogene roxaparvovec-rvox) as the first gene therapy for adults with severe hemophilia A
The clinics that rank highest pair a prescription with real bloodwork, not a checkout cart
Lower-body presentations, chronic low back pain and neuropathic foot pain, have also emerged as targets, likely because of their prevalence and the degree to which standard care consistently underperforms
ikir i's group published multiple studies on BPC-157's effects in rat models of ACL damage, Achilles tendon transection, and quadriceps muscle injury, consistently reporting accelerated structural recovery metrics [2,3]
Gallbladder disease: increased incidence of cholelithiasis and cholecystitis with rapid weight loss